The global Spatial Genomics & Transcriptomics market is expected to grow to USD 995.7 Million by 2029, up from USD 554.5 ...

The global Spatial Genomics & Transcriptomics market is expected to grow to USD 995.7 Million by 2029, up from USD 554.5 Million in 2024, at ...

The exosome diagnostic and therapeutic market is projected to grow at a CAGR of 9.1% from 2024 to 2034. Market valuation will increase from USD 88.56 million in 2024 to USD 211.6 million by 2034.

Bio-Techne Corporation TECH recently announced the launch of a new line of designer proteins engineered using advanced ...

The stock's fall snapped a four-day winning streak.

Highlights:,Drive-by VCs invest in multiple startups but with minimal involvement.,They focus on quick exits rather than long-term engagement.,Their strategy contrasts with traditional venture capital ...

The "Stem Cell Manufacturing Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The stem cell manufacturing market is forecasted to grow by USD 6.43 billion during 2023-2028, ...

Highlights,New portfolio of AI-engineered proteins designed to enhance cell culture and cellular therapy.,FGF basic Heat Stable available in both RUO and GMP formats, broadening research and ...

GMP Protein (E. Coli) Contract Manufacturing Market Set To Witness Significant Growth By 2025-2032: Abcam Plc, Genscript GMP Protein (E. coli) Contract manufacturing market 2025 GMP Protein (E. coli) ...

This was the stock's fourth consecutive day of gains.

The biotech group struggled as a whole in 2024, but analysts say the innovation that has always supported the biotech ...

Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its new ProPak™ GMP cytokines, alongside its portfolio of innovative products and solutions supporting cell and gene therapy ...